Keyword: U.S. Supreme Court
Merck's ruling at the Supreme Court could affect liability lawsuits across Big Pharma.
After a federal appeals court put Allergan's tribal licensing deal under review, judges scrutinized the arguments this week.
In response to the Supreme Court’s request to weigh in, the Solicitor General sided with Merck, saying that preemption should be determined by a judge, not a jury.
Dealing a blow to branded drugmakers, the U.S. Supreme Court found that inter partes review patent challenges are constitutional.
Novartis' Sandoz unit prevailed against Amgen in an appeal that's set to further shape the budding biosimilars field.
Merck's appeal to the Supreme Court has drawn in the U.S. Solicitor General, and the outcome could reverberate across the pharmaceutical industry.
The Supreme Court is set to decide whether the controversial inter partes review process is constitutional.
J&J dropped a lawsuit accusing Samsung Bioepis of infringing patents on Remicade, a $5 billion med that now faces biosimilar rivals.
Johnson & Johnson has successfully challenged two talc verdicts and wiped away nearly $500 million in liabilities.
J&J has escaped a $72 million verdict in its ongoing talcum powder saga, the first reversal of its numerous losses.